← Back to headlines
UAB Develops Drug for Spinal Cord Injury Treatment
Researchers at the Universitat Autònoma de Barcelona (UAB) have created a new drug aimed at treating spinal cord injuries, which has received orphan drug designation from the European Medicines Agency (EMA). The team is now proceeding with regulatory preclinical studies to confirm the product's safety.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
